Barclays Initiates Alphatec(ATEC.US) With Buy Rating, Announces Target Price $19
Barclays analyst Matt Miksic initiates coverage on $Alphatec(ATEC.US)$ with a buy rating, and sets the target price at $19.According to TipRanks data, the analyst has a success rate of 60.2% and a tot
Barclays Initiates Alphatec at Overweight
Alphatec Holdings (ATEC) has average rating of buy and price targets ranging from $17 to $32, according to analysts polled by Capital IQ.
Buy Rating on Alphatec Holdings: Undervalued Market Position and Strong Growth Outlook
Those Who Invested in Alphatec Holdings (NASDAQ:ATEC) Five Years Ago Are up 155%
General Counsel & Corporate Secretary Tyson Marshall Sold A Bunch Of Shares In Alphatec Holdings
Some Alphatec Holdings, Inc. (NASDAQ:ATEC) shareholders may be a little concerned to see that the General Counsel & Corporate Secretary, Tyson Marshall, recently sold a substantial US$547k worth of st
Alphatec(ATEC.US) Officer Sells US$546.52K in Common Stock
$Alphatec(ATEC.US)$ Officer Marshall Tyson Eliot sold 50,232 shares of common stock on Jun 12, 2024 at an average price of $10.88 for a total value of $546.52K.Source: Announcement What is statement o
Form 144 | Alphatec(ATEC.US) Officer Proposes to Sell 546.52K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 12, $Alphatec(ATEC.US)$ Officer TYSON MARSHALL intends to sell 50,232 shares of its common stock on Jun 12, with a total market value of approximately $546.52K. Source:
Alphatec Holdings: Strong Buy on Solid Execution and Positive Financial Outlook
Take Care Before Diving Into The Deep End On Alphatec Holdings, Inc. (NASDAQ:ATEC)
With a median price-to-sales (or "P/S") ratio of close to 3.3x in the Medical Equipment industry in the United States, you could be forgiven for feeling indifferent about Alphatec Holdings, Inc.'s (N
Analysts Are Bullish on These Healthcare Stocks: Zai Lab (ZLAB), Alphatec Holdings (ATEC)
Analysts Are Bullish on These Healthcare Stocks: Alphatec Holdings (ATEC), Terns Pharmaceuticals (TERN)
Here's What Analysts Are Forecasting For Alphatec Holdings, Inc. (NASDAQ:ATEC) After Its First-Quarter Results
Alphatec Holdings Shares Are Trading Lower Following Mixed Q1 Earnings.
Alphatec Holdings Shares Are Trading Lower Following Mixed Q1 Earnings.
Alphatec Holdings, Inc. (NASDAQ:ATEC) Q1 2024 Earnings Call Transcript
Alphatec Price Target Cut to $17.00/Share From $19.00 by Piper Sandler
Alphatec Price Target Cut to $17.00/Share From $19.00 by Piper Sandler
Alphatec Is Maintained at Overweight by Piper Sandler
Alphatec Is Maintained at Overweight by Piper Sandler
Piper Sandler: Maintaining the Alphatec Holdings (ATEC.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $19.00 to $17.00.
Piper Sandler: Maintaining the Alphatec Holdings (ATEC.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $19.00 to $17.00.
Piper Sandler Maintains Overweight on Alphatec Holdings, Lowers Price Target to $17
Piper Sandler analyst Matthew O'Brien maintains Alphatec Holdings with a Overweight and lowers the price target from $19 to $17.
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Aquestive Therapeutics (AQST) and Inspire Medical Systems (INSP)
Alphatec Price Target Maintained With a $23.00/Share by Needham
Alphatec Price Target Maintained With a $23.00/Share by Needham